Amyotrophic Lateral Sclerosis gene therapy (Insmed)

N/A

Report date: 2024/03/26 17:38:13

Base Information

Drug NameAmyotrophic Lateral Sclerosis gene therapy (Insmed)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesInsmed Inc
China Registration ClassN/A

Develop Information

Active CompaniesInsmed Inc
Inactive CompaniesN/A
Active IndicationsAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A